弹性成像与磁共振成像诊断NAFLD的准确性:系统综述与荟萃分析
该系统综述与荟萃分析纳入82项研究共14,609例成人NAFLD患者,以组织学为参考标准,评估VCTE、pSWE、2DSWE、MRE和MRI对肝纤维化及NASH的诊断准确性。MRE对显著纤维化、进展期纤维化和肝硬化的sAUC分别为0.91、0.92和0.90,VCTE分别为0.83、0.85和0.89;MRE诊断NASH的sAUC为0.83。成功获取的弹性成像检查对进展期纤维化和肝硬化具有可接受的诊断准确性,但缺乏意向诊断分析和预设阈值验证。
要点
- MRE对显著纤维化、进展期纤维化和肝硬化的sAUC分别为0.91、0.92和0.90。
- VCTE对显著纤维化、进展期纤维化和肝硬化的sAUC分别为0.83、0.85和0.89。
- 仅3项(4%)研究报告意向诊断分析,15项(18%)报告预设阈值的诊断准确性。
核心结论
- 弹性成像检查成功获取时,对进展期纤维化和肝硬化具有可接受的诊断准确性。
- 由于缺乏意向诊断分析和预设阈值验证,这些检查的潜在临床影响无法充分评估。
研究设计与样本
- 系统综述与荟萃分析,检索PubMED/MEDLINE、EMBASE和Cochrane Library。
- 纳入82项研究,共14,609例成人NAFLD患者,以组织学为参考标准。
- 采用随机效应双变量logit-normal模型计算敏感度、特异度和sAUC的汇总估计值。
主要发现
- 诊断显著纤维化的sAUC:VCTE 0.83,MRE 0.91,pSWE 0.86,2DSWE 0.75。
- 诊断进展期纤维化的sAUC:VCTE 0.85,MRE 0.92,pSWE 0.89,2DSWE 0.72。
- 诊断肝硬化的sAUC:VCTE 0.89,MRE 0.90,pSWE 0.90,2DSWE 0.88。
- MRE诊断NASH的sAUC为0.83。
- 3项(4%)研究报告意向诊断分析,15项(18%)研究报告预设阈值的诊断准确性。
关键数值与推荐
- 显著纤维化sAUC:MRE 0.91,pSWE 0.86,VCTE 0.83,2DSWE 0.75。
- 进展期纤维化sAUC:MRE 0.92,pSWE 0.89,VCTE 0.85,2DSWE 0.72。
- 肝硬化sAUC:MRE 0.90,pSWE 0.90,VCTE 0.89,2DSWE 0.88。
- NASH诊断sAUC:MRE 0.83。
临床怎么用
- 弹性成像检查成功获取时可用于NAFLD患者进展期纤维化和肝硬化的无创评估。
- MRE在各项纤维化分期中sAUC最高,但需结合可及性和成本考虑。
- 因缺乏意向诊断分析和预设阈值验证,结果解读需谨慎。
局限性
- 仅3项(4%)研究报告意向诊断分析。
- 仅15项(18%)研究报告预设阈值的诊断准确性。
- 上述局限导致这些检查的潜在临床影响无法充分评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic resonance elastography (MRE), and magnetic resonance imaging (MRI) have been proposed as non-invasive tests for patients with non-alcoholic fatty liver disease (NAFLD). This study evaluated their diagnostic accuracy for liver fibrosis and non-alcoholic steatohepatitis (NASH). METHODS: PubMED/MEDLINE, EMBASE and the Cochrane Library were searched for studies examining the diagnostic accuracy of these index tests, against histology as the reference standard, in adult patients with NAFLD. Two authors independently screened and assessed methodological quality of studies and extracted data. Summary estimates of sensitivity, specificity and area under the curve (sAUC) were calculated for fibrosis stages and NASH, using a random effects bivariate logit-normal model. RESULTS: We included 82 studies (14,609 patients). Meta-analysis for diagnosing fibrosis stages was possible in 53 VCTE, 11 MRE, 12 pSWE and 4 2DSWE studies, and for diagnosing NASH in 4 MRE studies. sAUC for diagnosis of significant fibrosis were: 0.83 for VCTE, 0.91 for MRE, 0.86 for pSWE and 0.75 for 2DSWE. sAUC for diagnosis of advanced fibrosis were: 0.85 for VCTE, 0.92 for MRE, 0.89 for pSWE and 0.72 for 2DSWE. sAUC for diagnosis of cirrhosis were: 0.89 for VCTE, 0.90 for MRE, 0.90 for pSWE and 0.88 for 2DSWE. MRE had sAUC of 0.83 for diagnosis of NASH. Three (4%) studies reported intention-to-diagnose analyses and 15 (18%) studies reported diagnostic accuracy against pre-specified cut-offs. CONCLUSIONS: When elastography index tests are acquired successfully, they have acceptable diagnostic accuracy for advanced fibrosis and cirrhosis. The potential clinical impact of these index tests cannot be assessed fully as intention-to-diagnose analyses and validation of pre-specified thresholds are lacking. LAY SUMMARY: Non-invasive tests that measure liver stiffness or use magnetic resonance imaging (MRI) have been suggested as alternatives to liver biopsy for assessing the severity of liver scarring (fibrosis) and fatty inflammation (steatohepatitis) in patients with non-alcoholic fatty liver disease (NAFLD). In this study, we summarise the results of previously published studies on how accurately these non-invasive tests can diagnose liver fibrosis and inflammation, using liver biopsy as the reference. We found that some techniques that measure liver stiffness had a good performance for the diagnosis of severe liver scarring.
引用
- Selvaraj EA, Mózes FE, Jayaswal ANA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol. 2021. PMID: 33991635. doi:10.1016/j.jhep.2021.04.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。